Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial

Table 3 Discussions at patient-provider visits

		All participants	All non-routine recommendations	Disease-specific non-routine recommendations
Breast Cancer∞
	Risk of breast cancer	48 (22.8%)	29 (23.2%)	18 (32.7%)
	Mammography	125 (59.2%)	68 (54.4%)	33 (60.0%)
	Breast MRI	10 (4.7%)	8 (6.4%)	5 (9.1%)
	Tamoxifen	6 (2.8%)	5 (4%)	4 (7.3%)
Ovarian Cancer∞		19 (9.0%)	13 (10.4%)	6 (50%)
Colon cancer*
	Risk of colon cancer	113 (30.5%)	50 (29.2%)	39 (34.8%)
	Screening for colon cancer	260 (70.3%)	118 (69.0%)	83 (74.1%)
Thrombosis*		35 (9.5%)	18 (10.5%)	10 (41.7%)
Seeing a specialist*		82 (22.2%)	62 (36.3%)	n/a
Lifestyle choices*		192 (51.9%)	83 (48.5%)	n/a

∞Total N = 211 for all participants; 125 for all non-routine recommendations; 55 for breast cancer-specific non-routine recommendations; 12 for ovarian cancer-specific non-routine recommendations.
*Total N = 370 for all participants; 171 for all non-routine recommendations; 112 for colon cancer-specific non-routine recommendations; 24 for thrombosis-specific non-routine recommendations.

ISSN: 2731-4553